Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry.

MLA

Saladini, Francesco, et al. “Residual Phenotypic Susceptibility to Doravirine in Multidrug-Resistant HIV-1 from Subjects Enrolled in the PRESTIGIO Registry.” International Journal of Antimicrobial Agents, vol. 61, no. 3, Mar. 2023, p. 106737. EBSCOhost, https://doi.org/10.1016/j.ijantimicag.2023.106737.

APA

Saladini, F., Giammarino, F., Maggiolo, F., Ferrara, M., Cenderello, G., Celesia, B. M., Martellotta, F., Spagnuolo, V., Corbelli, G. M., Gianotti, N., Santoro, M. M., Rusconi, S., Zazzi, M., & Castagna, A. (2023). Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry. International Journal of Antimicrobial Agents, 61(3), 106737. https://doi.org/10.1016/j.ijantimicag.2023.106737

Chicago

Saladini, Francesco, Federica Giammarino, Franco Maggiolo, Micol Ferrara, Giovanni Cenderello, Benedetto M Celesia, Ferdinando Martellotta, et al. 2023. “Residual Phenotypic Susceptibility to Doravirine in Multidrug-Resistant HIV-1 from Subjects Enrolled in the PRESTIGIO Registry.” International Journal of Antimicrobial Agents 61 (3): 106737. doi:10.1016/j.ijantimicag.2023.106737.